CN101411770B - Medicament for treating blood stasis accumulation type multiple sclerosis symptoms - Google Patents

Medicament for treating blood stasis accumulation type multiple sclerosis symptoms Download PDF

Info

Publication number
CN101411770B
CN101411770B CN2008101595409A CN200810159540A CN101411770B CN 101411770 B CN101411770 B CN 101411770B CN 2008101595409 A CN2008101595409 A CN 2008101595409A CN 200810159540 A CN200810159540 A CN 200810159540A CN 101411770 B CN101411770 B CN 101411770B
Authority
CN
China
Prior art keywords
multiple sclerosis
medicine
blood stasis
accumulation type
type multiple
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2008101595409A
Other languages
Chinese (zh)
Other versions
CN101411770A (en
Inventor
李兰荣
顾宗英
管滨
王希英
Original Assignee
李兰荣
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 李兰荣 filed Critical 李兰荣
Priority to CN2008101595409A priority Critical patent/CN101411770B/en
Publication of CN101411770A publication Critical patent/CN101411770A/en
Application granted granted Critical
Publication of CN101411770B publication Critical patent/CN101411770B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses a novel medicine for treating blood stasis accumulation type multiple sclerosis, which takes giant knotweed, bupleurumm, radix paeoniae rubra, red sange root, peach kernel, yellow-corktree bark, tree peony bark and safflower as materials. The preparation method comprises: according to different characteristics and mixing ratio of each traditional Chinese medicine, the materials are subjected to water washing and drying, processing, weighting, decocting and concentration, deposition, depositing in alcohol, extraction, drying, crushing and weighing, and are prepared into capsules by a conventional method. The medicine has the advantages of unique formula, obvious curative effect and 100 percent of total effective rate.

Description

A kind of medicine for the treatment of blood stasis accumulation type multiple sclerosis symptoms
Technical field the invention belongs to technical field of Chinese medicines, relates to a kind of medicine for the treatment of brain section blood stasis accumulation type multiple sclerosis symptoms, is the Chinese patent medicine of feedstock production specifically with the Chinese herbal medicine.
The background technology blood stasis accumulation type multiple sclerosis symptoms is a heart and brain section common clinical.How cause because of stagnation of blood stasis.Usually adopt Western medicine or operative treatment.But western medicine is taken greatly, and the operative treatment patient suffering is big, directly brings spirit and burden economically for patient and family.
It is the medicine of the treatment blood stasis accumulation type multiple sclerosis symptoms of the rule of treatment to promote blood circulation active that summary of the invention the purpose of this invention is to provide a kind of, to overcome the deficiencies in the prior art.
The objective of the invention is according to pathogenetic understanding and the Therapeutic Principle thereof of motherland's traditional medicine blood stasis accumulation type multiple sclerosis symptoms, with reference to modern pharmacological research, therefrom filter out the demountable natural Chinese medicinal herb of promoting blood circulation, press the Chinese medical theory prescription, make the unobstructed effect of its performance heart and brain.
Medicine of the present invention is the medicament of being made by the following weight proportion raw material
Rhizoma Polygoni Cuspidati 12g Radix Bupleuri 15g Radix Paeoniae Rubra 10g Radix Salviae Miltiorrhizae 10g Semen Persicae 10g Cortex Phellodendri 12g Cortex Moutan 12g Flos Carthami 12g
Above-mentioned each component is made medicament capsule of the present invention according to a conventional method, through washing dry, concoct, weigh, water boiling concentration, precipitation, precipitate with ethanol, extractum, oven dry, pulverize, weigh, encapsulated processing step forms.
Medicine of the present invention is a Chinese medicine preparation, according to the theory of Chinese medical science prescription, selects that medicine is reasonable, dosage form is advanced, active, the treating both the principal and secondary aspects of a disease of promoting blood circulation.Chinese medicinal capsule of the present invention, through clinical observation patient for many years, evident in efficacy, the multiple sclerosis patient that stagnation of blood stasis is caused has remarkable result.
Clinical drug of the present invention is taken the result and is shown, following advantage is arranged:
1, to select natural plant for use be raw material in the present invention, and each component meets the pharmaceutical control law regulation, utilizes the comprehensive function treatment multiple sclerosis of the medicine of respectively distinguishing the flavor of, and no chemicals is nontoxic to human body, has no side effect, and is safe and reliable.
2, slow fire of the present invention is fried in shallow oil water and is concentrated, and effective ingredient scatters and disappears few, and the curative effect height is cheap, taking convenience, no any discomfort disease.
3, medicine of the present invention is obvious to the blood stasis accumulation type multiple sclerosis symptoms curative effect.
4, clinical drug of the present invention is observed, and can replace the medicine of other treatment blood stasis accumulation type multiple sclerosis symptoms.
For showing the therapeutic effect of medicine of the present invention to blood stasis accumulation type multiple sclerosis symptoms, the present invention is through the clinical observation of 2000 routine blood stasis accumulation type multiple sclerosis symptoms patient systems, and select medical history, the state of an illness, age, sex and multiple sclerosis patients 100 examples suitable to organize as a comparison with traditional therapy, wherein male 1000 examples, woman's 1000 examples, 35~80 years old age, course of disease February~2 year.Test group: the conventional medicine of stopping using, take medicine of the present invention; Matched group: take conventional medicine.Observation period is 1 month, checks after half a year, does not have recurrence and is produce effects, and sb.'s illness took a favorable turn is evident as effectively, and it is not obvious that sb.'s illness took a favorable turn is invalid.
Instructions of taking: every 0.5g, one time 23 times on the one, warm water delivery service.
Clinical realization the results are shown in Table 1.
Table 1: take medicine of the present invention and take conventional medicine
Observation of curative effect to the blood stasis accumulation type multiple sclerosis symptoms patient
Group Case load Produce effects (routine number) Effectively (routine number) Invalid (routine number) Total effective rate (%)
Test group 2000 1300 700 0 100
Matched group 100 0 65 35 65.0
T 2.48 5.62 2.10 3.75
P <0.05 <0.05 <0.05 <0.05 <0.05
As can be seen from Table 1, medicine of the present invention is obtained 1300 examples that have of significant curative effect to 2000 routine blood stasis accumulation type multiple sclerosis symptoms patients, accounts for 65.0%; That takes a turn for the better has 700 examples, accounts for 35.0%; Total effective rate reaches 100%.
The specific embodiment
Take by weighing raw material by following proportioning:
Rhizoma Polygoni Cuspidati 12g Radix Bupleuri 15g Radix Paeoniae Rubra 10g Radix Salviae Miltiorrhizae 10g Semen Persicae 10g Cortex Phellodendri 12g Cortex Moutan 12g Flos Carthami 12g
Above-mentioned each component is made medicament capsule of the present invention according to a conventional method, through washing dry, concoct, weigh, water boiling concentration, precipitation, precipitate with ethanol, extractum, oven dry, pulverize, weigh, encapsulated processing step forms.
Model case
1, grandson xx, man 62 years old, it is surplus March that blood stasis accumulation type multiple sclerosis symptoms is suffered from clinical examination, took medicament capsule of the present invention 1 month, and transference cure does not have recurrence in half a year, follow up a case by regular visits to after 1 year, and is normal.
2, Liu xx, man 53 years old, it is surplus that blood stasis accumulation type multiple sclerosis symptoms year is suffered from clinical examination, took medicament capsule of the present invention 2 months, and transference cure does not have recurrence in half a year, follow up a case by regular visits to after 1 year, and is normal.
3, Wu xx, man 54 years old, it is surplus that blood stasis accumulation type multiple sclerosis symptoms year is suffered from clinical examination, took medicament capsule of the present invention 4 months, and transference cure does not have recurrence in half a year, follow up a case by regular visits to after 1 year, and is normal.
4, Lee xx, woman 30 years old, it is surplus that blood stasis accumulation type multiple sclerosis symptoms 3 months is suffered from clinical examination, took medicament capsule of the present invention 2 months, and transference cure does not have recurrence in half a year, follow up a case by regular visits to after 1 year, and is normal.
5, woods xx, woman 50 years old, it is surplus that blood stasis accumulation type multiple sclerosis symptoms 3 months is suffered from clinical examination, took medicament capsule of the present invention 2 months, and transference cure does not have recurrence in half a year, follow up a case by regular visits to after 1 year, and is normal.

Claims (1)

1. a medicine for the treatment of blood stasis accumulation type multiple sclerosis symptoms is characterized in that it is the capsule of being made by the following weight proportion raw material: Rhizoma Polygoni Cuspidati 12g Radix Bupleuri 15g Radix Paeoniae Rubra 10g Radix Salviae Miltiorrhizae 10g Semen Persicae 10g Cortex Phellodendri 12g Cortex Moutan 12g Flos Carthami 12g.
CN2008101595409A 2008-12-01 2008-12-01 Medicament for treating blood stasis accumulation type multiple sclerosis symptoms Expired - Fee Related CN101411770B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2008101595409A CN101411770B (en) 2008-12-01 2008-12-01 Medicament for treating blood stasis accumulation type multiple sclerosis symptoms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2008101595409A CN101411770B (en) 2008-12-01 2008-12-01 Medicament for treating blood stasis accumulation type multiple sclerosis symptoms

Publications (2)

Publication Number Publication Date
CN101411770A CN101411770A (en) 2009-04-22
CN101411770B true CN101411770B (en) 2010-12-15

Family

ID=40592648

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008101595409A Expired - Fee Related CN101411770B (en) 2008-12-01 2008-12-01 Medicament for treating blood stasis accumulation type multiple sclerosis symptoms

Country Status (1)

Country Link
CN (1) CN101411770B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103933348A (en) * 2014-04-14 2014-07-23 韦江南 Traditional Chinese medicine for treating animal inner damage and preparation method thereof
CN105497704A (en) * 2015-12-23 2016-04-20 关东升 Traditional Chinese medicine for treating multiple sclerosis
CN108508123B (en) * 2018-03-07 2020-05-12 广西医科大学第一附属医院 Safflower scleroderma-resistant metabonomics analysis method based on liquid chromatography-mass spectrometry

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1093579A (en) * 1993-01-12 1994-10-19 王旭文 A kind of medicinal liquid for the treatment of the orthopaedics pertinacious disease

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1093579A (en) * 1993-01-12 1994-10-19 王旭文 A kind of medicinal liquid for the treatment of the orthopaedics pertinacious disease

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
曾年菊等.中医药治疗多发性硬化症的研究进展.《中医药导报》.2005,第11卷(第11期),第66-68页. *
李红霞等.中医药治疗多发性硬化的近况.《河北中医》.2004,第26卷(第7期),第552-553页. *

Also Published As

Publication number Publication date
CN101411770A (en) 2009-04-22

Similar Documents

Publication Publication Date Title
CN103083531B (en) Drug for treating diabetes
CN103933468A (en) Traditional Chinese medicine for treating acute pancreatitis
CN102631595B (en) Medicament for treating II-type diabetes mellitus and preparation method thereof
CN101411770B (en) Medicament for treating blood stasis accumulation type multiple sclerosis symptoms
CN102727779A (en) Pharmaceutical composition for treating ovarian cysts and preparation method thereof
CN102512564A (en) Traditional Chinese medicine for treating dysmenorrhea
CN102139049A (en) Traditional Chinese medicine for treating diabetic skin pruritus
CN101804189B (en) Drug for treating primary dysmenorrhea
CN104547532A (en) Traditional Chinese medicine preparation for treating migraine and preparation method of traditional Chinese medicine preparation
CN101491612B (en) Medicine for treating mammary hyperplasia and early breast cancer
CN103893502A (en) Traditional Chinese medicine for treating phlyctenular conjunctivitis
CN101411810B (en) Medicament for treating multiple sclerosis symptoms
CN101439112B (en) Medicament for treating leukoderma
CN1246031C (en) Chinese patent drug-Fuyan capsdule for treating chronic pelvic inflammation
CN102552520A (en) Blood circulation-promoting and pain-stopping medicament for treating chest stuffiness and pains and preparation process and application thereof
CN105641419A (en) Traditional Chinese medicine composition for treating Yin deficiency type cough caused by lung cancer
CN101411832A (en) Medicament for treating chronic gastritis
CN100493571C (en) Medicine for treating heart failure
CN101745048A (en) Medicine for treating type II diabetes and resisting aging
CN103800664A (en) Traditional Chinese medicine composition for treating menopausal syndrome
CN102988587A (en) Medicament for treating refractory insomnia and preparation method of medicament
CN103566349A (en) Medicinal composition for treating hyperglycemia and hyperlipidemia
CN103550668A (en) Traditional Chinese medicine for treating habitual abortion in gynecology
CN101411831B (en) Medicament for treating low fever
CN100551389C (en) A kind of medicine for the treatment of early bone tumor

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent for invention or patent application
CB03 Change of inventor or designer information

Inventor after: Li Lanrong

Inventor after: Gu Zongying

Inventor after: Guan Bin

Inventor after: Wang Xiying

Inventor before: Li Lanrong

Inventor before: Gu Zongying

Inventor before: Guan Bin

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: LI LANRONG GU ZONGYING GUAN BIN TO: LI LANRONG GU ZONGYING GUAN BIN WANG XIYING

C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20101215

Termination date: 20111201